KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Gains from Investment Securities (2021 - 2025)

Historic Gains from Investment Securities for Organon (OGN) over the last 5 years, with Q3 2025 value amounting to -$16.0 million.

  • Organon's Gains from Investment Securities rose 5294.12% to -$16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.0 million, marking a year-over-year decrease of 23200.0%. This contributed to the annual value of $6.9 million for FY2024, which is 2066.69% up from last year.
  • Organon's Gains from Investment Securities amounted to -$16.0 million in Q3 2025, which was up 5294.12% from -$24.0 million recorded in Q2 2025.
  • Organon's Gains from Investment Securities' 5-year high stood at $21.0 million during Q2 2023, with a 5-year trough of -$37.0 million in Q3 2023.
  • Its 5-year average for Gains from Investment Securities is -$9.4 million, with a median of -$7.5 million in 2023.
  • The largest annual percentage gain for Organon's Gains from Investment Securities in the last 5 years was 33333.33% (2023), contrasted with its biggest fall of 31111.11% (2023).
  • Organon's Gains from Investment Securities (Quarter) stood at -$5.0 million in 2021, then soared by 60.0% to -$2.0 million in 2022, then tumbled by 250.0% to -$7.0 million in 2023, then tumbled by 228.57% to -$23.0 million in 2024, then soared by 30.43% to -$16.0 million in 2025.
  • Its Gains from Investment Securities stands at -$16.0 million for Q3 2025, versus -$24.0 million for Q2 2025 and -$20.0 million for Q1 2025.